| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 63 |
| 1 | ALBUTEROL SULFATE | 59 |
| 2 | TIOTROPIUM BROMIDE | 45 |
| 3 | PREDNISONE | 39 |
| 4 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 33 |
| 5 | MONTELUKAST SODIUM | 33 |
| 6 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 32 |
| 7 | ALBUTEROL | 21 |
| 8 | CICLESONIDE | 20 |
| 9 | MEPOLIZUMAB | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CICLESONIDE | 20 | 0.0015 |
| 1 | TERAZOSIN HYDROCHLORIDE | 9 | 0.0010 |
| 2 | OMALIZUMAB | 63 | 0.0007 |
| 3 | GLYCOPYRROLATE | 4 | 0.0007 |
| 4 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0007 |
| 5 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| 6 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 32 | 0.0005 |
| 7 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 1 | 0.0005 |
| 8 | TELMISARTAN | 9 | 0.0005 |
| 9 | TRANDOLAPRIL TABLETS | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 63 |
| 1 | Corticosteroid [EPC] | 53 |
| 2 | Proton Pump Inhibitor [EPC] | 21 |
| 3 | Interleukin-5 Antagonist [EPC] | 19 |
| 4 | Thiazide Diuretic [EPC] | 12 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 9 |
| 6 | Insulin Analog [EPC] | 8 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 6 |
| 9 | Benzodiazepine [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 19 | 0.0276 |
| 1 | Anti-IgE [EPC] | 63 | 0.0007 |
| 2 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 5 | Recombinant Human Deoxyribonuclease 1 [EPC] | 3 | 0.0002 |
| 6 | Aminoglycoside Antibacterial [EPC] | 4 | 0.0001 |
| 7 | Thiazide Diuretic [EPC] | 12 | 0.0001 |
| 8 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 9 | Protease Inhibitor [EPC] | 2 | 0.0000 |